Novo Nordisk (NVO) Earnings
|
Expand Research on NVO
| Next EPS Date | 8/6/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +3.0% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/6/26  |
Q126 | N/A | $0.82 | N/A | N/A | $11.59B | N/A | N/A | N/A | ||
| 2/3/26 |
Q425 | $1.02 | $0.92 | +$0.10 | $12.53B | $11.99B | N/A |  | | Details | |
| 11/5/25 |
Q325 | DKK4.50 | N/A | N/A | DKK74.98B | DKK12.01B | N/A | | | Details | |
| 8/6/25 |
Q225 | DKK12.49 | N/A | N/A | DKK154.94B | DKK11.95B | N/A | | | Details | |
| 5/7/25 |
Q125 | DKK6.53 | N/A | N/A | DKK78.09B | DKK11.38B | N/A | | | Details | |
| 2/5/25 |
Q424 | DKK6.34 | N/A | N/A | DKK85.68B | DKK11.38B | N/A | | | Details | |
| 11/6/24 |
Q324 | DKK6.12 | N/A | N/A | DKK71.31B | DKK10.6B | N/A | | | Details | |
| 8/7/24 | Q224 | DKK10.17 | N/A | N/A | DKK133.41B | DKK9.98B | N/A | | | Details |
